News Related to Aethlon Medical

Related coverage linked through entity extraction aliases.

AI Transforms Oncology Trials; Aethlon Advances Hemopurifier Cancer Study in Australia

Mar 18, 2026

Agentic AI models are streamlining oncology clinical trial design and reducing phase II to III failure risk. Separately, Aethlon Medical progresses its Hemopurifier device trial in Australia with strong safety data and accelerated patient recruitment.

Aethlon Medical Reports Q3 2026 Results, Advances Hemopurifier Oncology Trial

Feb 13, 2026

Aethlon Medical reported Q3 2026 financial results with a $2.06 million operating loss while advancing its Australian oncology trial of the Hemopurifier device. The company achieved 27% year-to-date cost reductions and targets a late March safety review.